China BCT Pharmacy Group, Inc.
CNBI · OTC
3/31/2013 | 12/31/2012 | 9/30/2012 | 6/30/2012 | |
|---|---|---|---|---|
| Market Cap | $10 | $8 | $25 | $57 |
| - Cash | $23 | $22 | $19 | $20 |
| + Debt | $16 | $16 | $11 | $10 |
| Enterprise Value | $3 | $2 | $17 | $48 |
| Revenue | $67 | $54 | $55 | $61 |
| % Growth | 23% | -2.3% | -9.3% | – |
| Gross Profit | $11 | $8 | $11 | $13 |
| % Margin | 16.9% | 14.9% | 19.4% | 21.9% |
| EBITDA | $7 | $3 | $6 | $9 |
| % Margin | 10.1% | 6% | 11.5% | 15.1% |
| Net Income | $5 | $2 | $4 | $6 |
| % Margin | 6.9% | 2.9% | 7.5% | 10.5% |
| EPS Diluted | 0.09 | 0.041 | 0.08 | 0.13 |
| % Growth | 120% | -48.9% | -38.5% | – |
| Operating Cash Flow | $3 | $1 | -$1 | -$11 |
| Capital Expenditures | -$2 | -$3 | -$0 | -$1 |
| Free Cash Flow | $1 | -$2 | -$2 | -$12 |